Roivant Sciences Stock In The News

ROIV Stock  USD 10.66  0.24  2.30%   
Our overall analysis of Roivant Sciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Roivant Sciences. The specific impact of Roivant Sciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Roivant Sciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Roivant Sciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Roivant Sciences Backtesting and Roivant Sciences Hype Analysis.
For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Roivant Sciences Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
https://www.globenewswire.com/news-release/2025/03/03/3035733/14025/en/Genevant-Sciences-and-Arbutus-Biopharma-Initiate-International-Patent-Infringement-Enforcement-Actions-Against-Moderna.html
 Neutral
Macroaxis News: globenewswire.com
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
https://www.globenewswire.com/news-release/2025/03/03/3035732/0/en/Genevant-Sciences-and-Arbutus-Biopharma-Initiate-International-Patent-Infringement-Enforcement-Actions-Against-Moderna.html
 Neutral
Yahoo News
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
https://finance.yahoo.com/news/genevant-sciences-arbutus-biopharma-initiate-141500151.html
 Neutral
Yahoo News
Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board
https://finance.yahoo.com/news/early-warning-report-issued-pursuant-130000850.html
 Neutral
Yahoo News
Roivant Sciences price target lowered to $12 from $13 at BofA
https://finance.yahoo.com/news/roivant-sciences-price-target-lowered-150039117.html
 Bullish
Yahoo News
News Flash: Analysts Just Made A Captivating Upgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) Forecasts
https://finance.yahoo.com/news/news-flash-analysts-just-made-110308191.html
 Bullish
Yahoo News
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update
https://finance.yahoo.com/news/roivant-reports-financial-results-third-120000467.html
 Neutral
Yahoo News
Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care
https://finance.yahoo.com/news/zest-health-announces-13m-funding-120000498.html
 Bullish
Macroaxis News: globenewswire.com
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025
https://www.globenewswire.com/news-release/2025/01/29/3017566/34323/en/Roivant-to-Report-Financial-Results-for-the-Third-Quarter-Ended-December-31-2024-and-Provide-Business-Update-on-Monday-February-10-2025.html
 Neutral
Yahoo News
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025
https://finance.yahoo.com/news/roivant-report-financial-results-third-210500003.html
 Neutral

Roivant Sciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Roivant and other traded companies coverage with news coverage. We help investors stay connected with Roivant headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Roivant Stock performance. Please note that trading solely based on the Roivant Sciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Roivant Sciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Roivant Sciences investors visualize upcoming and past events in order to time the market based on Roivant Sciences noise-free hype analysis.
Roivant Sciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Roivant earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Roivant Sciences that are available to investors today. That information is available publicly through Roivant media outlets and privately through word of mouth or via Roivant internal channels. However, regardless of the origin, that massive amount of Roivant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Roivant Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Roivant Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Roivant Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Roivant Sciences alpha.

Roivant Largest EPS Surprises

Earnings surprises can significantly impact Roivant Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-11
2024-12-31-0.24-0.19880.041217 
2022-06-28
2022-03-31-0.32-0.270.0515 
2024-11-12
2024-09-30-0.26-0.313-0.05320 
2023-08-14
2023-06-30-0.3-0.38-0.0826 
2023-11-13
2023-09-30-0.31-0.4-0.0929 
2023-02-13
2022-12-31-0.39-0.49-0.125 
View All Earnings Estimates

Roivant Sciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Roivant Sciences Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
zacks News
12th of March 2025
Wall Street Analysts Believe Montes Archimedes Acquisition Could Rally 60 percent Heres is...
at zacks.com 
news
5th of March 2025
Roivant Sciences Raised to Strong-Buy at Cantor Fitzgerald
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
3rd of March 2025
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforce...
at gurufocus.com 
Macroaxis News: globenewswire.com
25th of February 2025
Early Warning Report Issued Pursuant to National Instrument 62103 Roivant announces Resign...
at globenewswire.com 
news
19th of February 2025
Insider Selling Roivant Sciences Ltd. CAO Sells 227,500 Shares of Stock
at thelincolnianonline.com 
zacks News
14th of February 2025
All You Need to Know About Montes Archimedes Acquisition Rating Upgrade to Buy
at zacks.com 
news
12th of February 2025
Roivant Sciences Given Buy Rating at HC Wainwright
at thelincolnianonline.com 
Yahoo News
11th of February 2025
Roivant Sciences Ltd Q3 2024 Earnings Call Highlights Strategic Moves and Financial ...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
7th of February 2025
What To Expect From Roivant Sciences Ltd Q3 2025 Earnings
at gurufocus.com 

Roivant Sciences Investors Sentiment

The influence of Roivant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Roivant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Roivant Sciences' public news can be used to forecast risks associated with an investment in Roivant. The trend in average sentiment can be used to explain how an investor holding Roivant can time the market purely based on public headlines and social activities around Roivant Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Roivant Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Roivant Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Roivant Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Roivant Sciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Roivant Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Roivant Sciences' short interest history, or implied volatility extrapolated from Roivant Sciences options trading.

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.